Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PharmaZell and Novasep the closing of their merger, following exclusive negotiations initiated in September 2021. This strategic merger creates a technology driven, CDMO and API manufacturer.
read more
Adents has addressed a compliance issue through its recently introduced, Blockchain-based Adents NovaTrack product.
read more
Glen Research has achieved ISO 9001:2015 certification.
read more
Friday, February 21, 2020
Sihuan announced Xuanzhu Biopharmaceutical acquired all interests and intellectual property rights of plazomicin.
read more
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services announced a development collaboration agreement to evaluate AJICAP.
read more
Atrin Pharmaceuticals has announced receipt of a Phase 1 Small Business Technology Transfer (STTR) Award (R41CA203436) for approximately $300,000 from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The award supports ...
read more
Monday, February 01, 2021
Avacta has entered into a collaboration agreement with Bruker to evaluate the Affimer-based, bead assisted mass spectrometry SARS-CoV-2 assay, that the Group has developed with Adeptrix.
read more
Wednesday, March 17, 2021
Altimmune has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza.
read more
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. “Tapping into two decades’ experience of ...
read more
Tuesday, December 06, 2022
CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of innovative Active Pharmaceutical Ingredients (APIs), Lipid Excipients, and Drug Products, is proud to announce that as of 1 December 2022, it has joined the ...
read more
Thursday, November 13, 2025
GenoSafe inaugurated its new 1,200 m² laboratories at the Genopole biocluster in Évry-Courcouronnes, designed and equipped in accordance with Good Manufacturing Practices (GMP).
read more
Catalent announced it began Phase 2 clinical trials of MGB Biopharma.
read more
Wednesday, December 18, 2019
Civica Rx and Hikma Pharmaceuticals announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines.
read more
Sanofi and MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune-therapies.
read more
Tuesday, December 07, 2021
BrainStorm Cell Therapeutics Inc., a developer of cellular therapies for neurodegenerative diseases, and Catalent, a provider of services enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of ...
read more